Corporate News 25-Jun-24
USFDA classifies inspection of Cipla's Patalganga unit as 'Voluntary Action Indicated'
Cipla announced that the United States Food and Drug Administration (USFDA) vide communication dated 25 June 2024 has classified the inspection of the company's manufacturing facility in Patalganga as Voluntary Action Indicated (VAI).
Previous News
Cipla to table results
( Corporate News - 03-Oct-24 10:15 )
Nifty scales above 26,050; IT shares advance
( Market Commentary - Mid-Session 26-Sep-24 10:37 )
Cipla’s UK arm inks pact to acquire 6.9124% stake in Cipla Jiangsu Pharmaceuticals
( Hot Pursuit - 26-Sep-24 10:27 )
Cipla to acquire JV partners' 6.91% in Cipla Jiangsu
( Corporate News - 25-Sep-24 17:38 )
Cipla Ltd up for third consecutive session
( Hot Pursuit - 11-Sep-24 13:06 )
Cipla announces board meeting date
( Corporate News - 04-Sep-24 17:50 )
Cipla vice-chairman M.K. Hamied resigns
( Hot Pursuit - 04-Sep-24 08:56 )
Board of Cipla approves change in directorate
( Corporate News - 03-Sep-24 18:49 )
Cipla Ltd spurts 1.99%, rises for fifth straight session
( Hot Pursuit - 30-Aug-24 13:00 )
Cipla Ltd up for five straight sessions
( Hot Pursuit - 12-Aug-24 13:00 )
Cipla Ltd gains for third straight session
( Hot Pursuit - 08-Aug-24 13:05 )
Other Stories
ITD Cementation India wins order of Rs 1,937 cr
03-Oct-24 10:35
NIIT Learning Systems allots 1,666 equity shares under ESOP
03-Oct-24 10:30
Ashoka Metcast to discuss results
03-Oct-24 10:29
Emerald Finance to declare Quarterly Result
03-Oct-24 10:29
Rhetan TMT schedules board meeting
03-Oct-24 10:29
Shrenik to table results
03-Oct-24 10:29
Universal Arts to declare Quarterly Result
03-Oct-24 10:28
Three M Paper Boards to conduct board meeting
03-Oct-24 10:28
Arkade Developers to declare Quarterly Result
03-Oct-24 10:28
Worth Investment & Trading Company announces board meeting date
03-Oct-24 10:28
Back
Top
